• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Harmful errors in radiology suite top national database

Article

The number of reported medication errors associated with radiological services is relatively small. The percentage of errors that result in patient harm, however, is alarmingly high, according to a report released in January by the United States Pharmacopeia.

The number of reported medication errors associated with radiological services is relatively small. The percentage of errors that result in patient harm, however, is alarmingly high, according to a report released in January by the United States Pharmacopeia.

Of the 2032 reported medication errors that occurred in radiological services between 2000 and 2004, 12% were categorized as harmful. This percentage is seven times higher than the percentage of harm seen in the overall USP data for the same five-year period, said lead author John P. Santell, director of USP educational program initiatives.

The American College of Radiology took issue with the report and its inclusion of errors occurring in cardiac cath labs. Fewer than 1% of all cardiac cath procedures are performed by radiologists. These labs had the highest percentage (40%) of medication errors cited in the report. Other areas reviewed were radiology and nuclear medicine.

The ACR also noted that the error rate of 0.00008% is more than 3700 times better than the lowest hospital-wide medication error rate (0.3%) cited by a recent Institute of Medicine report on this issue.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.